Effect of Ayurvedic Management in Decompensated Liver Cirrhosis an observational single group retrospective study.

Decompensated Liver Cirrhosis (DLC) is the advanced and irreversible stage of chronic liver disease where the liver loses its functional capacity and presents with complications like ascites, jaundice, hepatic encephalopathy, variceal bleeding, coagulopathy and fluid retention. Liver transplantation is the only definitive treatment in modern medicine, but due to high cost, limited donor availability and strict eligibility criteria, most patients rely on supportive or palliative care. In Ayurveda, liver disorders are described under Yakrit Vikara, Kamala, Kumbha Kamala and Jalodara, caused mainly by aggravated Pitta and Rakta leading to progressive liver dysfunction. Ayurvedic management focuses on Shodhana (mainly Virechana), Samana, Rasayana, Tikshna dravyas, Kshara karma and dietary regulation including Takra, Dugdha, Yavagu, light and pitta-shamaka ahara along with fluid-salt restriction. This retrospective observational single-group study aims to evaluate the effect of Ayurvedic management in patients of Decompensated Liver Cirrhosis treated at P.D. Patel Ayurvedic Hospital. Hospital records from 2021–2025 will be analysed for age, diagnosis, symptoms, treatment details, laboratory parameters and Child-Pugh score. Improvement in symptoms like ascites, oedema, jaundice, appetite, urine output, abdominal girth and biochemical markers including bilirubin, albumin, SGPT, SGOT and INR will be assessed before and after treatment. Since there is a lack of systematically documented evidence regarding Ayurvedic management in advanced liver disorders, this study aims to provide clinical data and real-world outcomes to support future research and evidence-based practice. It bridges classical Ayurvedic principles with modern clinical evaluation to assess the efficacy of Shamana–Shodhana therapy in improving survival chances, quality of life and functional health status in Decompensated Liver Cirrhosis.